Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 5/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22304522 | 0.74 | NPSR1 (0.40) | ABCB1NPSR1MEN1KMT2ALMNA | |
| SCHEMBL14301030 | 0.74 | ABCB1 (0.46) | ABCB1NPSR1MEN1KMT2ALMNA | |
| SCHEMBL16174415 | 0.73 | CYP1A2 (0.51) | LMNAKDM4E | |
| SCHEMBL11441862 | 0.69 | CA9 (0.39) | MEN1KMT2AMAPK1ALDH1A1MAPT | |
| SCHEMBL11441863 | 0.69 | CA9 (0.39) | MEN1KMT2AMAPK1ALDH1A1MAPT | |
| SCHEMBL11441865 | 0.69 | CA9 (0.39) | MEN1KMT2AMAPK1ALDH1A1MAPT | |
| SCHEMBL29034995 | 0.68 | ALDH1A1 (0.49) | ABCB1NPSR1MEN1KMT2AMAPK1 | |
| SCHEMBL15032899 | 0.67 | TSHR (0.52) | MAPK1MAPTGAAPOLB | |
| SCHEMBL17324119 | 0.66 | AMY1A (0.41) | ABCB1NPSR1MEN1KMT2ALMNA | |
| SCHEMBL25943770 | 0.66 | LMNA (0.45) | LMNAALDH1A1KDM4ESMN1; SMN2ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3917983-B1 | BETA-HYDROXYPHOSPHONATE FUNCTIONALIZED POLYOLS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-02-01 | — | — | EP | disclosed |
| US-20220119427-A1 | BETA-HYDROXYPHOSPHONATE FUNCTIONALIZED POLYOLS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-04-21 | — | — | US | disclosed |
| WO-2020160094-A2 | BETA-HYDROXYPHOSPHONATE FUNCTIONALIZED POLYOLS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-08-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220119427-A1 | BETA-HYDROXYPHOSPHONATE FUNCTIONALIZED POLYOLS | IDH1, PHYKPL, IDH3B | ABCB1 2050/4885NPSR1 1615/4885MEN1 2204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.